Atlantic Health System has partnered with NeuroFlow, a behavioral health care software company, to launch a collaborative care model across 16 accountable care organization (ACO) sites.
Simply put, NeuroFlow leverages its technology to alert care teams about high-risk and rising-risk patients.
“Given the rising demand for behavioral health services, we were looking for a solution that could streamline behavioral health screenings, provide customized patient education and coaching, along with access to [behavioral health] collaborating professionals,” Dr. Jim Barr, Atlantic Health System vice president of physician value-based programs and chief medical officer of accountable care organizations, said in a statement.
“The NeuroFlow platform identifies and prioritizes behavioral health concerns in our populations, collects data to help us understand the whole person, and supports management with clinical decision insights and performance frameworks,” Barr continued.
According to NeuroFlow’s website, the collaborative care model includes:
NeuroFlow also will help monitor treatment outcomes, an approach that has been proven to reduce emergency department visits by 34%, according to Atlantic Health.
The Morristown-based health care provider will roll out the NeuroFlow screenings for about 30,000 adult patients across its system in June, followed by the enrollment of younger patients after that.
“Technology is the force-multiplier needed to advance behavioral health care and close the care gaps that exist for patients,” said NeuroFlow Chief Medical Officer Dr. Tom Zaubler. “This partnership will support the clinical team at Atlantic Health as they launch the collaborative care model and work toward improving access for their adult and pediatric patients as demand for services continues to increase.”
Atlantic Health also recently added new technology to expand its treatment options for prostate cancer patients: the Focal One robotic technology, which can help in the removal of discrete lesions within the prostate.